A set of sequester proteins could be blood-based biomarkers for assessment of early stages of cognitive decline.
No takes yet. Share an insight, caveat, or question.
Uchida et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: